Back to
Verition Fund Management LLC
PRAX
Showing 5 of 8 quarters
Position history for
Verition Fund Management LLC's holdings in PRAXIS PRECISION MEDICINES I
No. Verition Fund Management exited its PRAX (Praxis Precision Medicines) position in Q3 2025. Its Q2 2025 13F listed 118,482 shares worth $5M. Verition Fund Management already held PRAX in its Q4 2023 13F, the earliest on record, and held it in 7 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$32.2M
Total Shares Change
-559,151
Quarter-by-Quarter History